Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?

Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?

Background: Metabolic syndrome and related metabolic disturbances represent a state of low-grade inflammation, which accelerates insulin resistance, type 2 diabetes (T2D) and cardiovascular disease (CVD) progression. Among antidiabetic medications, sodium glucose co-transporter (SGLT) 2 inhibitors a...

Full description

Bibliographic Details
Main Authors: Asmaa Elrakaybi, Katharina Laubner, Qian Zhou, Martin J. Hug, Jochen Seufert
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Molecular Metabolism
Subjects:
SGLT2 inhibitors
Inflammation
Metabolism
Heart failure
Cardiovascular disease
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877822001181

Internet

http://www.sciencedirect.com/science/article/pii/S2212877822001181

Similar Items